Causes of Death and Subsequent Treatment after Initial Radical or Palliative Therapy of Stage iii Non-Small-Cell Lung Cancer

Abstract

The eventual life-ending event in stage iii nsclc varied for the patients who qualified for, and were treated with, radical or curative intent and for the patients who received palliative-intent therapy. Utilization of systemic chemotherapy in patients not fit for radical therapy is low.